Skip to search formSkip to main contentSkip to account menu

DC101 monoclonal antibody

Known as: DC101 Mab, Mab DC101, DC101 
A monoclonal antibody that inhibits binding of vascular endothelial growth factor to its receptor, thereby inhibiting angiogenesis and tumor growth… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Anti-angiogenic antibodies (Ab) such as bevacizumab (αVEGF) and ramucirumab (αVEGFR2) suppress tumor growth by disrupting the… 
2007
2007
El receptor para el factor de crecimiento epidermico (EGFR), una molecula altamente expresada en tumores epiteliales, provee un… 
2007
2007
  • 2007
  • Corpus ID: 12189706
The t r ihydroxamate bifunctional chelating agent (BCA), trisuccin, has been shown to be a potential ligand for radiolabeling of… 
2006
2006
URLs The role of circulating endothelial progenitors (CEPs; bone-marrow derived endothelial progenitor cells that enter the… 
2006
2006
A monoclonal antibody (MAb) designated PD41 (IgGlk) was gener ated by hyperimmunizing BALB/c mice with a membrane preparation… 
2005
2005
Since conventional therapies are directly dependent on the supply of either drugs or oxygen, a key question is whether… 
Highly Cited
2000
Highly Cited
2000
Thymidine phosphorylase (TP), an enzyme involved in the thymidine synthesis and degradation, has been shown to promote tumor… 
2000
2000
1 The pro-inflammatory cytokine interleukin (IL)-6 can bind to cells lacking the IL-6 receptor (IL-6R) when it forms a complex… 
1992
1992
F(ab')@injectedi.v. into an ovariancancer patient,localized specificallyin the tumor. Ovariancancertissuesamplesob tamed 2 days…